




Searching News Database: Pain Therapeutics
HSMN NewsFeed - 6 Sep 2018
SiteOne Therapeutics Appoints John Hunter, Ph.D. as Chief Scientific Officer
SiteOne Therapeutics Appoints John Hunter, Ph.D. as Chief Scientific Officer
HSMN NewsFeed - 21 Mar 2017
Pain Therapeutics Announces Positive Regulatory Guidance for REMOXY(TM) ER
Pain Therapeutics Announces Positive Regulatory Guidance for REMOXY(TM) ER
HSMN NewsFeed - 29 Mar 2016
Pain Therapeutics Resubmits REMOXY New Drug Application to the U.S. Food and Drug Administration
Pain Therapeutics Resubmits REMOXY New Drug Application to the U.S. Food and Drug Administration
HSMN NewsFeed - 23 Apr 2015
Pain Therapeutics Announces Appointment of Senior Vice President, Regulatory Affairs
Pain Therapeutics Announces Appointment of Senior Vice President, Regulatory Affairs
HSMN NewsFeed - 7 Jan 2013
Celator(R) Pharmaceuticals Announces Appointment of Lisa DeLuca as Vice President, Regulatory Affairs
Celator(R) Pharmaceuticals Announces Appointment of Lisa DeLuca as Vice President, Regulatory Affairs
HSMN NewsFeed - 23 Aug 2010
Archimedes Pharma US Announces New US Headquarters In Bedminster, New Jersey
Archimedes Pharma US Announces New US Headquarters In Bedminster, New Jersey
HSMN NewsFeed - 10 Jun 2008
Pain Therapeutics and King Pharmaceuticals Announce Submission of New Drug Application for Remoxy
Pain Therapeutics and King Pharmaceuticals Announce Submission of New Drug Application for Remoxy
HSMN NewsFeed - 28 Apr 2008
Labopharm Appoints Dr. Claire Brullé as Senior Vice-President and Chief Medical Officer
Labopharm Appoints Dr. Claire Brullé as Senior Vice-President and Chief Medical Officer
HSMN NewsFeed - 7 Aug 2007
NeurAxon Appoints Robert Medve, M.D., as Chief Medical and Regulatory Officer
NeurAxon Appoints Robert Medve, M.D., as Chief Medical and Regulatory Officer
HSMN NewsFeed - 3 Jan 2007
Victory Pharma, Inc. Signs NAPRELAN(R) Agreement; US Field Sales Force to Expand
Victory Pharma, Inc. Signs NAPRELAN(R) Agreement; US Field Sales Force to Expand
HSMN NewsFeed - 7 Sep 2006
King Pharmaceuticals Announces Strategic Acquisition of Avinza(R) from Ligand Pharmaceuticals
King Pharmaceuticals Announces Strategic Acquisition of Avinza(R) from Ligand Pharmaceuticals
HSMN NewsFeed - 5 May 2006
ORADUR(TM) Technology Milestone: Remoxy(TM) (ORADUR-Based Oxycodone) Commences Pivotal Phase III Program
ORADUR(TM) Technology Milestone: Remoxy(TM) (ORADUR-Based Oxycodone) Commences Pivotal Phase III Program
Additional items found! 26

Members Archive contains
26 additional stories matching:
Pain Therapeutics
(Password required)
Pain Therapeutics
(Password required)